ArticleJACS Au2026
Multisite Phosphorylation Regulates the Structure and Auto-Inhibitory Function of the Intrinsically Disordered N‑Terminal Domain of p53.
Article in JACS Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multisite phosphorylation plays an important role in essential cellular processes such as cell cycle control and circadian rhythm regulation and is also closely involved in the onset and progression of cancer and neurodegenerative diseases. As one of the most critical human tumor suppressor proteins, p53 is greatly modulated by phosphorylation. It contains numerous phosphorylation sites in its intrinsically disordered terminal domains. Specifically, multisite phosphorylation in the N-terminal domain (NTD) stimulates its autoinhibitory function, thereby repressing its downstream DNA transcriptional activity. However, the molecular mechanisms by which phosphorylation regulates p53 autoinhibition remain largely unclear. In this study, we employed all-atom molecular dynamics simulations combined with enhanced sampling methods to investigate how phosphorylation influences the structural properties of the intrinsically disordered p53-NTD, as well as its interaction with the DNA-binding domain (DBD). Our results show that phosphorylation significantly modulates the structural properties of p53-NTD, including both local structures and long-range residue interactions. T55 phosphorylation promotes the insertion of the aromatic rings of F54 and W53 into the DNA-binding pocket (DBP) of DBD and synergistically stabilizes the NTD-DBD interactions. Although S46 single phosphorylation would not induce NTD binding to the DBP, it can amplify the self-inhibitory ability of pT55 by reducing the dynamic conformational entropy of NTD. This study reveals the detailed molecular mechanism by which phosphorylation on p53-NTD regulates the structure and self-inhibition, providing crucial insights into the molecular basis underlying intrinsically disordered protein functions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.